MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defective
US9023787B2 · kind B2 · utility
2Cited by
11References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2013 |
| Grant date | May 5, 2015 |
| Priority date | — |
| Expiry date | May 13, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16B30/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and pharmaceutical compositions for treating cellular proliferative disorders, e.g., in patients having one or more p53-deficient cells, screening assays for identifying such compounds, and methods for treating such disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.